NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

Beachhyena, Adding a game theory thought / scenario to your synthetic short position theory which I believe is very possible:

Assume the convergence of events:
- An economic recession starts to take hold in the broader market, say in Q2
- DCVax-L gets approved in April or May, removes “binary risk”
- NWBO then shifts from "speculative biotech" to both a structural defensive-position (medical is recession proof) and massive-upside-potential for New Money.
- Retail investors recognize Long-Term opportunity and become “diamond hands”, a situation where Shorts have hard time covering.

Emerging trend:
- Small cap alpha (stock selection) outperforms passive large cap ETFs

Sentiment shifts from Speculative to Asymmetric Risk-Reward (Post-Approval):
- Will win lawsuit against 7 market makers, anticipate a major non-dilutive cash
- Synthetic short contracts likely in the >1B shares, creates a potential major short squeeze scenario
- DCVax platform potential to be recognized as the base layer for a personalize vaccine, with the long-term potential to cure cancer. A tumor-agnostic and stage agnostic solution with strong immune memory, that all oncologists and patients want.